Soluble CD141-152 confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay

Weiming Yu, Elisa Soprana, Giovanna Cosentino, Manuela Volta, Henri S. Lichenstein, Giovanna Viale, Donata Vercelli

Research output: Contribution to journalArticlepeer-review

28 Scopus citations


CD14 is a pattern recognition receptor involved in the interaction with multiple ligands, including LPS from Gram-negative bacteria and lipoarabinomannan (LAM) from mycobacteria. While the interactions between LPS and soluble CD14 (sCD14) have been analyzed in detail, LAM/CD14 interactions remain uncharacterized due to the lack of suitable functional assays. We describe herein a novel bioassay for the analysis of CD14/ligand interactions. CD14-negative myeloid HL-60 cells up-regulate endogenous CD14 gene expression when stimulated with LPS in the presence of recombinant soluble CD141-348. Using the HL-60 bioassay, we showed that sCD141- 348 confers responsiveness not only to LPS, but also to LAM. The response to LAM, but not that to LPS, was highly dependent on LPS binding protein (LBP). The N-terminal half of CD14 was sufficient to mediate HL-60 responses to LAM, since HL-60 cells responded with similar efficiency when stimulated with LAM and LBP in the presence of sCD141-348 or sCD141-152. Thus, the N-terminal 152 amino acids of CD14 contain the site(s) involved in the interaction with LAM and LBP, as well as the residues required for LAM- dependent CD14 signaling.

Original languageEnglish (US)
Pages (from-to)4244-4251
Number of pages8
JournalJournal of Immunology
Issue number8
StatePublished - Oct 15 1998
Externally publishedYes

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology


Dive into the research topics of 'Soluble CD14<sub>1-152</sub> confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay'. Together they form a unique fingerprint.

Cite this